Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Johnson

Gastroenterology Norfolk, VA Medical Doctor

NPI 1447236112 CMS profile 20264

885 Kempsville Rd, Suite 114, Norfolk, VA 23502

Open in the dashboard

General payments

$58,038

139 records reported · program years 2019–2025

Research payments

$1,560

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$18,972 paid to institutions, not to them · program years 2019–2021

Through program year 2025, David Johnson of Norfolk, VA is reported in the CMS Open Payments database as having received $58,038 across 139 general payments and $1,560 in research payments paid to them. Separately, studies naming them as principal investigator received $18,972 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $114 5
2024 General $181 9
2024 Research $1,560 1
2023 General $17,737 18
2022 General $19,961 23
2021 General $26 2
2020 General $5,524 11
2019 General $14,494 71

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Johnson
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to David Johnson were reported at $114. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year David Johnson Gastroenterology median Middle half National median
2019 $14,494 $417 $126–$1,100 $163
2020 $5,524 $224 $74–$624 $114
2021 $26 $352 $106–$1,054 $132
2022 $19,961 $448 $129–$1,270 $149
2023 $17,737 $533 $150–$1,390 $160
2024 $181 $605 $160–$1,606 $164
2025 $114 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boehringer Ingelheim International GmbH $30,780 9 payments
  2. Aries Pharmaceuticals, Inc. $13,518 4 payments
  3. Hikma Pharmaceuticals USA $5,000 1 payment
  4. Global Blood Therapeutics, Inc. $3,328 1 payment
  5. Ironwood Pharmaceuticals, Inc $2,048 1 payment
  6. Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,829 24 payments
  7. AbbVie, Inc. $825 48 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $138 10 payments
  9. Janssen Biotech, Inc. $135 14 payments
  10. Gilead Sciences, Inc. $109 7 payments
  11. Other $328 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $49,674 15 payments
  2. Honoraria $5,000 1 payment
  3. Food and Beverage $1,964 122 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $1,400 1 payment
Products named General payments · program years 2019–2025
  1. Dexilant $5,000 1 payment
  2. OXBRYTA $3,328 1 payment
  3. PLENVU $1,400 1 payment
  4. XIFAXAN $420 22 payments
  5. HUMIRA $329 16 payments
  6. RINVOQ $270 12 payments
  7. SKYRIZI $234 13 payments
  8. CREON $180 9 payments
  9. LINZESS $155 8 payments
  10. STELARA $135 14 payments
  11. Other $679 45 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Boehringer Ingelheim International GmbH $1,560 1 payment

Records

140 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record